15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children. DITRAME ANRS 049 Study Group.
In a randomised, double-blind comparison of a maternal short regimen of oral zidovudine with placebo in West Africa the 15-month efficacy of zidovudine in preventing mother-to-child transmission of HIV-1 infection was estimated at 30% (95% CI -2 to 52).